Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity
Judith L. Thijs
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorRenée Fiechter
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorBarbara Giovannone
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorMarjolein S. de Bruin-Weller
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorEdward F. Knol
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorCarla A. F. M. Bruijnzeel-Koomen
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorJulia Drylewicz
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorStefan Nierkens
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorCorresponding Author
DirkJan Hijnen
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Correspondence
DirkJan Hijnen, Department of Dermatology, Erasmus MC, Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands, Internal address NA-511, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Email: [email protected]
Search for more papers by this authorJudith L. Thijs
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorRenée Fiechter
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorBarbara Giovannone
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorMarjolein S. de Bruin-Weller
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorEdward F. Knol
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorCarla A. F. M. Bruijnzeel-Koomen
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Search for more papers by this authorJulia Drylewicz
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorStefan Nierkens
Laboratory of Translational Immunology, Utrecht, The Netherlands
Search for more papers by this authorCorresponding Author
DirkJan Hijnen
Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands
Laboratory of Translational Immunology, Utrecht, The Netherlands
Correspondence
DirkJan Hijnen, Department of Dermatology, Erasmus MC, Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands, Internal address NA-511, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Email: [email protected]
Search for more papers by this authorNierkens and Hijnen are senior authors.
Supporting Information
| Filename | Description |
|---|---|
| all13839-sup-0001-FigE1A.jpgimage/jpg, 46.2 KB | |
| all13839-sup-0002-FigE1B.jpgimage/jpg, 120 KB | |
| all13839-sup-0003-FigE2.epsimage/eps, 110 KB | |
| all13839-sup-0004-FigE3A.epsimage/eps, 8.7 KB | |
| all13839-sup-0005-FigE3B.epsimage/eps, 9.3 KB | |
| all13839-sup-0006-FigE3C.epsimage/eps, 6 KB | |
| all13839-sup-0007-Supinfo.docxapplication/docx, 43.1 KB |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Thijs J, Fiechter SI, Sleeman MA, et al. EASI p-EASI: utilising a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients. J Allergy Clin Immunol. 2017; 140(6): 1703-1705.
- 2Thijs JL, Drylewicz J, Fiechter R, et al. EASI p-EASI: utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients. J Allergy Clin Immunol. 2017; 140: 1703-1705.
- 3Ostler MW, Porter JH, Buxton OM. Dried blood spot collection of health biomarkers to maximize participation in population studies. J Vis Exp. 2014; 83: 1-9.
- 4Gros E, Bussmann C, Bieber T, Forster I, Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol. 2009; 124: 753-760.
- 5Thijs J, Krastev T, Weidinger S, et al. Biomarkers for atopic dermatitis: a systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015; 15: 453-460.
- 6Pennings J, Siljee JE, Imholz S, et al. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting. Dis Markers. 2014; 2014: 509821.
- 7Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem. 2005; 51: 1854-1866.
- 8Burns D, Brunner L, Rajendran S, Johnson B, Ma M, Wang J. Validation of a ligand binding assay using dried blood spot sampling. AAPS J. 2013; 15: 123-131.
- 9Koster RA, Alffenaar J, Greijdanus B, Uges D. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta 2013; 115: 47-54.
Citing Literature
